2024 Q4 Form 10-Q Financial Statement

#000149315224045236 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q4
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.541M
YoY Change 1299.6%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $3.541M
YoY Change 1299.6%
Operating Profit -$8.981M
YoY Change 2923.89%
Interest Expense $480.0K
YoY Change -81.91%
% of Operating Profit
Other Income/Expense, Net -$1.111M -$225.0K
YoY Change -495.5% -148.18%
Pretax Income -$3.286M
YoY Change -214.57%
Income Tax
% Of Pretax Income
Net Earnings -$10.09M -$3.286M
YoY Change -2687.77% -214.57%
Net Earnings / Revenue
Basic Earnings Per Share -$0.22
Diluted Earnings Per Share -$0.22 -$0.29
COMMON SHARES
Basic Shares Outstanding 47.94M shares 47.70M shares
Diluted Shares Outstanding 45.17M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.00K
YoY Change -78.22%
Cash & Equivalents $1.587M $22.00K
Short-Term Investments
Other Short-Term Assets $14.00K
YoY Change 75.0%
Inventory
Prepaid Expenses $14.00K
Receivables
Other Receivables
Total Short-Term Assets $3.307M $36.00K
YoY Change 4033.82% -66.97%
LONG-TERM ASSETS
Property, Plant & Equipment $14.83K $1.968K
YoY Change -99.7% -99.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets $43.70M
YoY Change
Total Long-Term Assets $2.070M $43.70M
YoY Change -95.14% -85.66%
TOTAL ASSETS
Total Short-Term Assets $3.307M $36.00K
Total Long-Term Assets $2.070M $43.70M
Total Assets $5.377M $43.74M
YoY Change -87.41% -85.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.494M $64.00K
YoY Change 162254.13% -14.67%
Accrued Expenses $4.327M
YoY Change 43.47%
Deferred Revenue
YoY Change
Short-Term Debt $383.8K $3.481M
YoY Change -85.03% 343.44%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $11.01M $7.872M
YoY Change 191.7% 103.1%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $10.84M
YoY Change -1.19%
Total Long-Term Liabilities $10.84M
YoY Change -1.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.01M $7.872M
Total Long-Term Liabilities $10.84M
Total Liabilities $18.68M $18.71M
YoY Change 29.85% 26.05%
SHAREHOLDERS EQUITY
Retained Earnings -$43.05M -$18.67M
YoY Change 200.89% 26.73%
Common Stock $4.573K $4.023K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$13.30M -$18.67M
YoY Change
Total Liabilities & Shareholders Equity $5.377M $43.74M
YoY Change -87.41% -85.65%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q4
OPERATING ACTIVITIES
Net Income -$10.09M -$3.286M
YoY Change -2687.77% -214.57%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$296.0K
YoY Change -44.26%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$600.0K
YoY Change
Cash From Investing Activities -$600.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 917.0K
YoY Change 138.18%
NET CHANGE
Cash From Operating Activities -296.0K
Cash From Investing Activities -600.0K
Cash From Financing Activities 917.0K
Net Change In Cash 21.00K
YoY Change -114.38%
FREE CASH FLOW
Cash From Operating Activities -$296.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001831979
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1739280 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-5074276 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q4 SDST Promissory Notes Issued
PromissoryNotesIssued
usd
CY2023Q4 us-gaap Other Long Term Investments
OtherLongTermInvestments
usd
CY2024Q3 SDST Simple Agreement For Future Equity Notes
SimpleAgreementForFutureEquityNotes
usd
CY2023Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
usd
CY2023Q4 SDST Earnout Liability
EarnoutLiability
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2024Q3 us-gaap Revenues
Revenues
usd
CY2023Q3 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2024Q3 SDST Simple Agreement For Future Equity Note Issuance Costs
SimpleAgreementForFutureEquityNoteIssuanceCosts
usd
CY2024Q3 SDST Other Transaction Costs
OtherTransactionCosts
usd
SDST Other Transaction Costs
OtherTransactionCosts
usd
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
usd
us-gaap Interest Income Other
InterestIncomeOther
usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
usd
CY2023Q3 SDST Change In Fair Value Of Earn Out Shares
ChangeInFairValueOfEarnOutShares
usd
SDST Change In Fair Value Of Earn Out Shares
ChangeInFairValueOfEarnOutShares
usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
usd
CY2023Q3 SDST Change In Fair Value Of Investment In Equity Securities
ChangeInFairValueOfInvestmentInEquitySecurities
usd
SDST Change In Fair Value Of Investment In Equity Securities
ChangeInFairValueOfInvestmentInEquitySecurities
usd
CY2024Q3 SDST Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
usd
CY2023Q3 SDST Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
usd
SDST Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
usd
CY2024Q3 SDST Fair Value Of Simple Agreement For Future Equity Notes Issuance Costs
FairValueOfSimpleAgreementForFutureEquityNotesIssuanceCosts
usd
CY2023Q3 SDST Fair Value Of Simple Agreement For Future Equity Notes Issuance Costs
FairValueOfSimpleAgreementForFutureEquityNotesIssuanceCosts
usd
SDST Fair Value Of Simple Agreement For Future Equity Notes Issuance Costs
FairValueOfSimpleAgreementForFutureEquityNotesIssuanceCosts
usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2023Q1 SDST Retroactive Application Of Recapitalization
RetroactiveApplicationOfRecapitalization
usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2023Q1 SDST Retroactive Application Of Recapitalization
RetroactiveApplicationOfRecapitalization
usd
CY2023Q4 SDST Retroactive Application Of Recapitalization
RetroactiveApplicationOfRecapitalization
usd
CY2024Q3 SDST Adjustments To Additional Paid In Capital Earnout Shares
AdjustmentsToAdditionalPaidInCapitalEarnoutShares
usd
CY2023Q4 SDST Retroactive Application Of Recapitalization
RetroactiveApplicationOfRecapitalization
usd
SDST Adjustments To Additional Paid In Capital Earnout Shares
AdjustmentsToAdditionalPaidInCapitalEarnoutShares
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
SDST Change In Fair Value Of Investment In Equity Securities
ChangeInFairValueOfInvestmentInEquitySecurities
usd
SDST Fair Value Of Simple Agreement For Future Equity Issuance Costs
FairValueOfSimpleAgreementForFutureEquityIssuanceCosts
usd
SDST Fair Value Adjustment Of Warrants Write Off Of Contingent Warrant
FairValueAdjustmentOfWarrantsWriteOffOfContingentWarrant
usd
SDST Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
usd
SDST Change In Fair Value Of Earn Out Shares
ChangeInFairValueOfEarnOutShares
usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
usd
SDST Safe Notes Issuance Costs
SafeNotesIssuanceCosts
usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
SDST Payments To Promissory Note Issued
PaymentsToPromissoryNoteIssued
usd
SDST Proceeds From Investor Deposits
ProceedsFromInvestorDeposits
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
SDST Payment Of Safe Note Issuance Cost To Related Parties
PaymentOfSafeNoteIssuanceCostToRelatedParties
usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
usd
SDST Proceeds From Business Combination And Issuance Of Pipe Shares
ProceedsFromBusinessCombinationAndIssuanceOfPIPEShares
usd
SDST Repayment Of Sponsor Promissory Notes
RepaymentOfSponsorPromissoryNotes
usd
SDST Repurchase Of Unvested Shares
RepurchaseOfUnvestedShares
usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
SDST Unpaid Deferred Transaction Cost
UnpaidDeferredTransactionCost
usd
SDST Conversion Of Legacy Safe Notes
ConversionOfLegacySafeNotes
usd
SDST Conversion Of Legacy Convertible Notes
ConversionOfLegacyConvertibleNotes
usd
SDST Sponsor Earn Out Share Liability
SponsorEarnOutShareLiability
usd
SDST Issuance Of Common Stock To Sponsor
IssuanceOfCommonStockToSponsor
usd
SDST Net Liabilities Assumed Upon Closing Of Business Combination
NetLiabilitiesAssumedUponClosingOfBusinessCombination
usd
SDST Issuance Of Common Stock To Non Redeeming Shareholders
IssuanceOfCommonStockToNonRedeemingShareholders
usd
SDST Unpaid Safe Note Issuance Costs
UnpaidSafeNoteIssuanceCosts
usd
SDST Unpaid Preacquisition Capital Project Cost
UnpaidPreacquisitionCapitalProjectCost
usd
SDST Antidilutive Securities Excluded From Computation Of Restricted Stock Options
AntidilutiveSecuritiesExcludedFromComputationOfRestrictedStockOptions
shares
SDST Antidilutive Securities Excluded From Computation Of Restricted Stock Units
AntidilutiveSecuritiesExcludedFromComputationOfRestrictedStockUnits
shares
SDST Antidilutive Securities Excluded From Computation Of Performance Stock Units
AntidilutiveSecuritiesExcludedFromComputationOfPerformanceStockUnits
shares
SDST Antidilutive Securities Excluded From Computation Of Sponsor Earnout Shares Note3
AntidilutiveSecuritiesExcludedFromComputationOfSponsorEarnoutSharesNote3
shares
SDST Antidilutive Securities Excluded From Computation Of Sponsor Earnout Shares Note3
AntidilutiveSecuritiesExcludedFromComputationOfSponsorEarnoutSharesNote3
shares
SDST Antidilutive Securities Excluded From Computation Of Public Warrants
AntidilutiveSecuritiesExcludedFromComputationOfPublicWarrants
shares
SDST Antidilutive Securities Excluded From Computation Of Private Placement Warrants
AntidilutiveSecuritiesExcludedFromComputationOfPrivatePlacementWarrants
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
shares
CY2023Q4 SDST Sponsor Earn Out Shares Fair Value Disclosure
SponsorEarnOutSharesFairValueDisclosure
usd
CY2024Q3 SDST Consulting Expenses
ConsultingExpenses
usd
SDST Consulting Expenses
ConsultingExpenses
usd
CY2024Q3 us-gaap Other Expenses
OtherExpenses
usd
CY2023Q3 us-gaap Other Expenses
OtherExpenses
usd
us-gaap Other Expenses
OtherExpenses
usd
CY2024Q3 SDST Consulting And Other Expense
ConsultingAndOtherExpense
usd
SDST Consulting And Other Expense
ConsultingAndOtherExpense
usd
CY2024Q3 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
usd
CY2023Q3 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
usd
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
usd
CY2023Q4 SDST Advisory Fees
AdvisoryFees
usd
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39875
dei Entity Registrant Name
EntityRegistrantName
STARDUST POWER INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-3863616
dei Entity Address Address Line1
EntityAddressAddressLine1
15 E. Putnam Ave
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 378
dei Entity Address City Or Town
EntityAddressCityOrTown
Greenwich
dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06830
dei City Area Code
CityAreaCode
(800)
dei Local Phone Number
LocalPhoneNumber
742-3095
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47936140 shares
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1587086 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1271824 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1024850 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
426497 usd
CY2024Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
199724 usd
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
1005109 usd
CY2024Q3 SDST Promissory Notes Issued
PromissoryNotesIssued
495397 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
3307057 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2703430 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14830 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1968 usd
CY2024Q3 SDST Pre Acquistion Land Cost
PreAcquistionLandCost
1937487 usd
CY2023Q4 SDST Pre Acquistion Land Cost
PreAcquistionLandCost
100000 usd
CY2024Q3 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
67562 usd
CY2023Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
218556 usd
CY2024Q3 us-gaap Other Long Term Investments
OtherLongTermInvestments
50000 usd
CY2024Q3 us-gaap Assets
Assets
5376936 usd
CY2023Q4 us-gaap Assets
Assets
3023954 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6494165 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1256792 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
4129258 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
208107 usd
CY2024Q3 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
4408 usd
CY2023Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
2990 usd
CY2024Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
383797 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
72967 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11011628 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1540856 usd
CY2023Q4 SDST Simple Agreement For Future Equity Notes
SimpleAgreementForFutureEquityNotes
5212200 usd
CY2024Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
4693859 usd
CY2024Q3 SDST Earnout Liability
EarnoutLiability
2972800 usd
CY2024Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
3259 usd
CY2023Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
5660 usd
CY2024Q3 us-gaap Liabilities
Liabilities
18681546 usd
CY2023Q4 us-gaap Liabilities
Liabilities
6758716 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
69033000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47872445 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47872445 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41499772 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41499772 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
4573 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
4023 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29741789 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
54800 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43050972 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3793585 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-13304610 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3734762 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5376936 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3023954 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8980965 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
778455 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11483389 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1902653 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-8980965 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-778455 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11483389 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1902653 usd
CY2023Q3 SDST Simple Agreement For Future Equity Note Issuance Costs
SimpleAgreementForFutureEquityNoteIssuanceCosts
29655 usd
SDST Simple Agreement For Future Equity Note Issuance Costs
SimpleAgreementForFutureEquityNoteIssuanceCosts
466302 usd
CY2023Q3 SDST Other Transaction Costs
OtherTransactionCosts
35690 usd
SDST Other Transaction Costs
OtherTransactionCosts
452519 usd
CY2024Q3 us-gaap Interest Income Other
InterestIncomeOther
3397 usd
us-gaap Interest Income Other
InterestIncomeOther
3397 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
8558 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
10637 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
7111 usd
CY2024Q3 SDST Change In Fair Value Of Earn Out Shares
ChangeInFairValueOfEarnOutShares
1636100 usd
SDST Change In Fair Value Of Earn Out Shares
ChangeInFairValueOfEarnOutShares
1636100 usd
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2753964 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2753964 usd
CY2024Q3 SDST Change In Fair Value Of Investment In Equity Securities
ChangeInFairValueOfInvestmentInEquitySecurities
11678 usd
SDST Change In Fair Value Of Investment In Equity Securities
ChangeInFairValueOfInvestmentInEquitySecurities
-150994 usd
SDST Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
471400 usd
SDST Fair Value Of Simple Agreement For Future Equity Notes Issuance Costs
FairValueOfSimpleAgreementForFutureEquityNotesIssuanceCosts
955000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1111347 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-65345 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2702498 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-925932 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-10092312 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-843800 usd
us-gaap Net Income Loss
NetIncomeLoss
-14185887 usd
us-gaap Net Income Loss
NetIncomeLoss
-2828585 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45171254 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40453289 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41694909 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40367188 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45171254 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40453289 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41694909 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40367188 shares
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
90 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
90 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-245505 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-245415 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1984695 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-843800 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-2828495 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
90 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
90 usd
us-gaap Net Income Loss
NetIncomeLoss
-2828585 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-2828495 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3734762 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3734762 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1399213 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
59599 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
100 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2694362 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
58125 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
100 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-7710413 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-10092312 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
6916355 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
783 usd
CY2024Q3 SDST Stock Issued During Period Shares Issued Upon Conversion Of Safes
StockIssuedDuringPeriodSharesIssuedUponConversionOfSafes
6367200 usd
CY2024Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2571400 usd
CY2024Q3 SDST Issuance Of Common Stock Upon Reverse Capitalization
IssuanceOfCommonStockUponReverseCapitalization
5483019 usd
CY2024Q3 SDST Stock Issued During Period Shares Issued Upon Exercise Of Common Stock Warrants
StockIssuedDuringPeriodSharesIssuedUponExerciseOfCommonStockWarrants
1626619 usd
CY2024Q3 SDST Adjustments To Additional Paid In Capital Transaction Costs
AdjustmentsToAdditionalPaidInCapitalTransactionCosts
7501223 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-13304610 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3734762 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3734762 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3734762 usd
us-gaap Net Income Loss
NetIncomeLoss
-14185887 usd
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
7034079 usd
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
983 usd
SDST Stock Issued During Period Shares Issued Upon Exercise Of Common Stock Warrants
StockIssuedDuringPeriodSharesIssuedUponExerciseOfCommonStockWarrants
1626619 usd
SDST Stock Issued During Period Shares Issued Upon Conversion Of Safe
StockIssuedDuringPeriodSharesIssuedUponConversionOfSafe
6367200 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2571400 usd
SDST Issuance Of Common Stock Upon Reverse Capitalization
IssuanceOfCommonStockUponReverseCapitalization
5483019 usd
SDST Adjustments To Additional Paid In Capital Transaction Costs
AdjustmentsToAdditionalPaidInCapitalTransactionCosts
7501223 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-13304610 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-13304610 usd
us-gaap Net Income Loss
NetIncomeLoss
-14185887 usd
us-gaap Net Income Loss
NetIncomeLoss
-2828585 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7034079 usd
SDST Change In Fair Value Of Investment In Equity Securities
ChangeInFairValueOfInvestmentInEquitySecurities
-150994 usd
SDST Fair Value Of Simple Agreement For Future Equity Issuance Costs
FairValueOfSimpleAgreementForFutureEquityIssuanceCosts
955000 usd
SDST Fair Value Adjustment Of Warrants Write Off Of Contingent Warrant
FairValueAdjustmentOfWarrantsWriteOffOfContingentWarrant
2753964 usd
SDST Change In Fair Value Of Convertible Notes
ChangeInFairValueOfConvertibleNotes
471400 usd
SDST Change In Fair Value Of Earn Out Shares
ChangeInFairValueOfEarnOutShares
1636100 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1074 usd
SDST Safe Notes Issuance Costs
SafeNotesIssuanceCosts
466302 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
461575 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4055728 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
733998 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
458618 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
11240 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
49616 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8514161 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1582429 usd
SDST Payments For Preacquisition Land Cost
PaymentsForPreacquisitionLandCost
726102 usd
SDST Payments For Preacquisition Land Cost
PaymentsForPreacquisitionLandCost
25000 usd
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
50000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11155 usd
SDST Payments To Promissory Note Issued
PaymentsToPromissoryNoteIssued
492000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1279257 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25000 usd
SDST Proceeds From Investor For Issuance Of Safe Notes
ProceedsFromInvestorForIssuanceOfSafeNotes
200000 usd
SDST Proceeds From Investor For Issuance Of Safe Notes
ProceedsFromInvestorForIssuanceOfSafeNotes
2000000 usd
SDST Proceeds From Investor Deposits
ProceedsFromInvestorDeposits
1000000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1000000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
1000000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
90 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1561655 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2100000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4134056 usd
SDST Payment Of Safe Note Issuance Cost To Related Parties
PaymentOfSafeNoteIssuanceCostToRelatedParties
435000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
510000 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
199170 usd
SDST Proceeds From Business Combination And Issuance Of Pipe Shares
ProceedsFromBusinessCombinationAndIssuanceOfPIPEShares
11639088 usd
SDST Repayment Of Sponsor Promissory Notes
RepaymentOfSponsorPromissoryNotes
1562834 usd
SDST Repurchase Of Unvested Shares
RepurchaseOfUnvestedShares
6003 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10108680 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2565090 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
315262 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
957661 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1271824 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1587086 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
957661 usd
us-gaap Interest Paid Net
InterestPaidNet
8814 usd
us-gaap Interest Paid Net
InterestPaidNet
7111 usd
SDST Unpaid Deferred Transaction Cost
UnpaidDeferredTransactionCost
3470991 usd
SDST Conversion Of Legacy Safe Notes
ConversionOfLegacySafeNotes
64 usd
SDST Conversion Of Legacy Convertible Notes
ConversionOfLegacyConvertibleNotes
26 usd
SDST Sponsor Earn Out Share Liability
SponsorEarnOutShareLiability
4608900 usd
SDST Issuance Of Common Stock To Sponsor
IssuanceOfCommonStockToSponsor
400 usd
SDST Net Liabilities Assumed Upon Closing Of Business Combination
NetLiabilitiesAssumedUponClosingOfBusinessCombination
14638315 usd
SDST Issuance Of Common Stock To Non Redeeming Shareholders
IssuanceOfCommonStockToNonRedeemingShareholders
13 usd
SDST Unpaid Safe Note Issuance Costs
UnpaidSafeNoteIssuanceCosts
31302 usd
SDST Unpaid Preacquisition Capital Project Cost
UnpaidPreacquisitionCapitalProjectCost
846385 usd
CY2024Q3 SDST Battery Grade Lithum Number Of Units
BatteryGradeLithumNumberOfUnits
50000
CY2023Q4 SDST Ordinary Shares Issued At Closing Of Business Combination
OrdinarySharesIssuedAtClosingOfBusinessCombination
127777 shares
CY2024Q3 us-gaap Share Price
SharePrice
10.00
CY2023Q4 SDST Business Acquisition Trading Days
BusinessAcquisitionTradingDays
P20D
CY2023Q4 SDST Business Acquisition Consecutive Trading Days
BusinessAcquisitionConsecutiveTradingDays
P30D
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_zbRFufYql52c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_861_zPqnErhNcFF2">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the unaudited condensed consolidated financial statements and accompanying notes. Those estimates and assumptions include, but are not limited to, useful life of computer and equipment, realization of deferred tax assets, fair valuation of investment in equity securities and fair valuation of stock based compensation, warrants, simple agreement for future equity notes (each a “SAFE note”), convertible notes and earnout shares. The Company evaluates estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from these estimates, and those differences could be material to the unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p>
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-10092312 usd
us-gaap Net Income Loss
NetIncomeLoss
-14185887 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43050972 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-13304610 usd
CY2024Q3 us-gaap Cash
Cash
1587086 usd
CY2024Q3 us-gaap Other Investments
OtherInvestments
10075002 usd
CY2024Q3 SDST Trust Account Proceeds Net
TrustAccountProceedsNet
1564086 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-10092312 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-843800 usd
us-gaap Net Income Loss
NetIncomeLoss
-14185887 usd
us-gaap Net Income Loss
NetIncomeLoss
-2828585 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
45171254 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45171254 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40453289 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40453289 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41694909 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41694909 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40367188 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40367188 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
125411 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
893985 shares
SDST Antidilutive Securities Excluded From Computation Of Restricted Stock Options
AntidilutiveSecuritiesExcludedFromComputationOfRestrictedStockOptions
851655 shares
SDST Antidilutive Securities Excluded From Computation Of Restricted Stock Units
AntidilutiveSecuritiesExcludedFromComputationOfRestrictedStockUnits
3281911 shares
SDST Antidilutive Securities Excluded From Computation Of Performance Stock Units
AntidilutiveSecuritiesExcludedFromComputationOfPerformanceStockUnits
506596 shares
SDST Antidilutive Securities Excluded From Computation Of Public Warrants
AntidilutiveSecuritiesExcludedFromComputationOfPublicWarrants
4864133 shares
SDST Antidilutive Securities Excluded From Computation Of Private Placement Warrants
AntidilutiveSecuritiesExcludedFromComputationOfPrivatePlacementWarrants
5566667 shares
CY2023Q4 us-gaap Deferred Costs
DeferredCosts
1005109 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
6496114 usd
CY2023Q4 SDST Equity Classified Instruments
EquityClassifiedInstruments
7501223 usd
CY2024Q3 us-gaap Deferred Costs
DeferredCosts
199724 usd
CY2023Q2 SDST Nonrefundable Payment
NonrefundablePayment
25000 usd
CY2023Q4 SDST Nonrefundable Payment
NonrefundablePayment
75000 usd
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1562030 usd
CY2024Q2 SDST Debt Instrument Payment For First Non Refundable Extension Payment
DebtInstrumentPaymentForFirstNonRefundableExtensionPayment
33333 usd
CY2024Q3 SDST Debt Instrument Payment For First Non Refundable Extension Payment
DebtInstrumentPaymentForFirstNonRefundableExtensionPayment
33333 usd
SDST Capital Project Costs
CapitalProjectCosts
1770821 usd
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47736650 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
SDST Fair Value Of Earnout Share Arrangement Amount
FairValueOfEarnoutShareArrangementAmount
25071000 usd
CY2024Q3 SDST Net Cash Proceeds Received From Reverse Recapitalization And Pipe Financing
NetCashProceedsReceivedFromReverseRecapitalizationAndPipeFinancing
9154761 usd
CY2024Q3 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
1564086 usd
CY2024Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
10075002 usd
CY2024Q3 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
921493 usd
CY2024Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1562834 usd
CY2024Q3 SDST Net Cash Proceeds Received From Reverse Recapitalization And Pipe Financing
NetCashProceedsReceivedFromReverseRecapitalizationAndPipeFinancing
9154761 usd
CY2024Q3 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
14638215 usd
CY2024Q3 SDST Adjustments To Additional Paid In Capital Business Combination
AdjustmentsToAdditionalPaidInCapitalBusinessCombination
-5483454 usd
CY2024Q3 SDST Adjustments To Additional Paid In Capital Transaction Costs
AdjustmentsToAdditionalPaidInCapitalTransactionCosts
7501223 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
As part of the closing of the Business Combination, the Company issued 1,000,000 shares to Global Partner Sponsor II, LLC (the “Sponsor”). These shares are subject to vesting (or forfeiture) based on achieving certain trading price thresholds following the closing (“Sponsor Earnout Shares”). Fifty percent of the Sponsor Earnout Shares will vest when the VWAP of the Common Stock price equals or exceeds $12.00 per share for a period of 20 trading days in a 30 trading day period, and the remaining fifty percent of the Sponsor Earnout Shares will vest when the VWAP of the Common Stock price equals or exceeds $14.00 per share for a period of 20 trading days in a 30 trading day period. There are no service conditions or any requirement for the participants to provide goods or services in order to vest in the Sponsor Earnout Shares. Accordingly, we determined that the Sponsor Earnout Shares are not within the scope of ASC 718. The accounting for the Sponsor Earnout Shares was evaluated under ASC Topic 480, “Distinguishing Liabilities from Equity”, and ASC Subtopic 815-40, “Derivatives and Hedging — Contracts in Entity’s Own Equity”, to determine if the Sponsor Earnout Shares should be classified as a liability or within equity. As part of the analysis, it was determined that the Sponsor Earnout Shares subject to vesting are freestanding from other shares of Combined Company Common Stock held by the Sponsor and do not meet the criteria in ASC 815-40 to be considered indexed to the Combined Company Common Stock, due to the settlement provisions including a change in control component which could impact the number of the Sponsor Earnout Shares are ultimately settled for, which is not an input to a fixed-for-fixed option pricing model. As a result, the Sponsor Earnout Shares will be classified as a liability. Subsequent changes in the fair value of the Sponsor Earnout shares will be reflected in the consolidated statement of operations.
CY2024Q3 SDST Sponsor Earn Out Shares Fair Value Disclosure
SponsorEarnOutSharesFairValueDisclosure
2972800 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47872445 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41499772 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41499772 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
2531232 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1191980 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P24M
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
125411 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y6M
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
313528 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.000002
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
188117 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.000002
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
125411 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.000002
CY2023Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2301120 shares
CY2024Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
0 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2278108 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2278108 shares
CY2023Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.0065
CY2023Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.0065
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14850 usd
CY2023Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
920448 shares
CY2023Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.0065
CY2023Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
6000 usd
SDST Shares Exercised Outstanding
SharesExercisedOutstanding
7667 usd
SDST Shares Exercised Outstanding
SharesExercisedOutstanding
8650 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1326979 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.57
SDST Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodGross
-219644 shares
SDST Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice
0.57
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
255680 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.60
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
851655 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.60 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.70 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0384 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0386 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2024Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10430800 shares
CY2024Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
SDST Class Of Warrant Or Rights Description
ClassOfWarrantOrRightsDescription
Once the Public Warrants become exercisable, the Company may redeem the outstanding Public Warrants in whole and not in part at a price of $0.01 per warrant upon a minimum of 30 days’ prior written notice of redemption, only in the event that the last sale price of the Common Stock equals or exceeds $18.00 per share for any 20 trading days within the 30-trading day period ending on the third trading day before the Company sends the notice of redemption to the Public Warrant holders, and that certain other conditions are met. Once the Public Warrants become exercisable, the Company may also redeem the outstanding Public Warrants in whole and not in part at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption, only in the event that the closing price of the common stock equals or exceeds $10.00 per share on the trading day prior to the date on which the Company sends the notice of redemption, and that certain other conditions are met. If the closing price of the common stock is less than $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders, the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants.
CY2023Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
218556 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
218556 usd
CY2024Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
67562 usd
CY2024Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
67562 usd
CY2023Q4 us-gaap Liabilities Related To Investment Contracts Fair Value Disclosure
LiabilitiesRelatedToInvestmentContractsFairValueDisclosure
5212200 usd
CY2023Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
5212200 usd
CY2024Q3 SDST Sponsor Earn Out Shares Fair Value Disclosure
SponsorEarnOutSharesFairValueDisclosure
2972800 usd
CY2024Q3 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
2972800 usd
CY2023Q3 SDST Consulting Expenses
ConsultingExpenses
147497 usd
SDST Consulting Expenses
ConsultingExpenses
1306935 usd
us-gaap Other Expenses
OtherExpenses
44186 usd
CY2023Q3 SDST Consulting And Other Expense
ConsultingAndOtherExpense
147497 usd
SDST Consulting And Other Expense
ConsultingAndOtherExpense
1351121 usd
SDST Capital Contribution In Exchange Of Subscription
CapitalContributionInExchangeOfSubscription
90 usd
CY2023Q2 SDST Capital Contribution In Exchange Of Subscription
CapitalContributionInExchangeOfSubscription
90 usd
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
1000000 usd
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
1000000 usd
us-gaap Interest Expense
InterestExpense
7111 usd
CY2024Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1053345 usd
CY2023Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
151284 usd
CY2024Q3 SDST Advisory Fees
AdvisoryFees
3000000 usd
CY2024Q3 us-gaap Other Liabilities
OtherLiabilities
75913 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
56823 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
4129258 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
208107 usd

Files In Submission

Name View Source Status
0001493152-24-045236-index-headers.html Edgar Link pending
0001493152-24-045236-index.html Edgar Link pending
0001493152-24-045236.txt Edgar Link pending
0001493152-24-045236-xbrl.zip Edgar Link pending
ex10-9.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sdst-20240930.xsd Edgar Link pending
Show.js Edgar Link pending
sdst-20240930_lab.xml Edgar Link unprocessable
sdst-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
sdst-20240930_cal.xml Edgar Link unprocessable
sdst-20240930_def.xml Edgar Link unprocessable